All Comments by Richard Bedlack
- Unintended Consequences of Approving Unproven Treatments-Hope, Hype, or Harm?
- Safety and Effectiveness of Long-term Intravenous Administration of Edaravone for Treatment of Patients With Amyotrophic Lateral Sclerosis.
- In Small Trial, EH301 Appears to Halt Progression of ALS
- Large ALS GWAS Identifies Modifiers of Survival
- Mexiletine Banishes Muscle Cramps in Phase 2 Trial of ALS
- Study Suggests Respiratory Pacemaker Reduces ALS Survival
- An α2-Na/K ATPase/α-adducin complex in astrocytes triggers non-cell autonomous neurodegeneration.
- Evidence Mounts That Mitochondrial Gene Is Bona Fide ALS, FTD Risk Factor
- Chicago—ALS Clinical Trials: New Hope After Phase 3 Setbacks
- Unusual ALS Case Highlights Variable Onset